Dr. Tepper describes the breakthrough of CGRP-targeted therapy for the prevention of migraine
Dr. Tepper describes the breakthrough of CGRP-targeted therapy for the prevention of migraine
Dr. Stewart J Tepper has working relationship with the companies listed: Accorda, Alder, Alexsa, Allergan, ATI, Alphasights, Amgen, Axsome, Biohaven, BioDelivery Sciences Intl, Cefaly, Charleston Labs, Decision Resources, CLG, Dr. Reddy's, ElectroCore, EliLilly, eNeuro, ExpertConnect, GSK, Guidepoint Global, Impel, M3 Global Research, Magellan Rx Mgmt, MedicXi, Novartis, Navigent Consulting, Neurolief, Pfizer, Nordy Biotech, Reckner Healthcare, Relevale, Satsuma, Scion Neurostim, Slingshot Insights, Sorrento, Sudler and Hennessey, Supernus, Teva, Theronica, Trinity Partners, XOC, Zosano